KWMG
ABBV icon

King Wealth Management Group’s AbbVie ABBV Stock Holding History

King Wealth Management Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$585K Buy
2,692
+23
+0.9% +$5.1K 0.07% 93
2025
Q4 		$610K Sell
2,669
-71
-3% -$16.2K 0.07% 92
2025
Q3 		$634K Buy
2,740
+3
+0.1% +$611 0.08% 87
2025
Q2 		$508K Buy
2,737
+14
+0.5% +$2.6K 0.07% 98
2025
Q1 		$571K Buy
2,723
+30
+1% +$5.83K 0.09% 86
2024
Q4 		$479K Sell
2,693
-4,925
-65% -$905K 0.07% 95
2024
Q3 		$1.5M Sell
7,618
-151
-2% -$28.2K 0.23% 49
2024
Q2 		$1.33M Buy
7,769
+85
+1% +$14.1K 0.22% 50
2024
Q1 		$1.4M Sell
7,684
-17
-0.2% -$2.93K 0.25% 49
2023
Q4 		$1.19M Buy
7,701
+5,038
+189% +$734K 0.23% 51
2023
Q3 		$397K Sell
2,663
-258
-9% -$37.9K 0.08% 90
2023
Q2 		$394K Buy
2,921
+39
+1% +$5.72K 0.08% 94
2023
Q1 		$459K Buy
2,882
+3
+0.1% +$459 0.1% 85
2022
Q4 		$465K Buy
2,879
+184
+7% +$28.2K 0.11% 84
2022
Q3 		$362K Buy
2,695
+225
+9% +$32.3K 0.09% 98
2022
Q2 		$378K Buy
2,470
+2
+0.1% +$306 0.09% 105
2022
Q1 		$400K Sell
2,468
-2,409
-49% -$350K 0.08% 106
2021
Q4 		$660K Sell
4,877
-466
-9% -$55K 0.12% 87
2021
Q3 		$576K Buy
5,343
+4
+0.1% +$457 0.12% 91
2021
Q2 		$601K Buy
5,339
+300
+6% +$33.8K 0.12% 85
2021
Q1 		$545K Sell
5,039
-142
-3% -$15.2K 0.12% 86
2020
Q4 		$555K Sell
5,181
-318
-6% -$30.6K 0.13% 88
2020
Q3 		$482K Buy
5,499
+2,495
+83% +$235K 0.13% 91
2020
Q2 		$295K Buy
+3,004
New +$264K 0.09% 113
2018
Q3 		– Sell
-36,226
Closed -$3.36M – 131
2018
Q2 		$3.36M Buy
36,226
+1,394
+4% +$136K 1.15% 23
2018
Q1 		$3.3M Buy
34,832
+1,685
+5% +$185K 1.17% 23
2017
Q4 		$3.21M Buy
33,147
+611
+2% +$57.6K 1.13% 23
2017
Q3 		$2.89M Sell
32,536
-14,269
-30% -$1.09M 1.07% 24
2017
Q2 		$3.39M Buy
46,805
+1,489
+3% +$100K 1.35% 20
2017
Q1 		$2.95M Buy
45,316
+1,107
+3% +$69.6K 1.23% 21
2016
Q4 		$2.77M Buy
44,209
+10,794
+32% +$659K 1.24% 20
2016
Q3 		$2.11M Buy
33,415
+3,562
+12% +$231K 1.05% 22
2016
Q2 		$1.85M Buy
29,853
+785
+3% +$47.8K 0.99% 22
2016
Q1 		$1.66M Buy
29,068
+669
+2% +$37.3K 0.89% 28
2015
Q4 		$1.68M Sell
28,399
-9,737
-26% -$561K 0.93% 27
2015
Q3 		$2.08M Sell
38,136
-22,408
-37% -$1.46M 1.28% 21
2015
Q2 		$4.07M Buy
60,544
+8
+0% +$522 2.22% 10
2015
Q1 		$3.54M Sell
60,536
-12,999
-18% -$785K 2.05% 12
2014
Q4 		$4.81M Buy
73,535
+17,596
+31% +$1.11M 2.56% 10
2014
Q3 		$3.23M Buy
55,939
+2,974
+6% +$165K 2.03% 12
2014
Q2 		$3.01M Buy
52,965
+13,012
+33% +$683K 1.85% 15
2014
Q1 		$2.05M Sell
39,953
-12,413
-24% -$627K 1.42% 18
2013
Q4 		$2.77M Buy
52,366
+5,094
+11% +$250K 1.58% 19
2013
Q3 		$2.11M Sell
47,272
-290
-0.6% -$12.9K 1.38% 20
2013
Q2 		$1.97M Buy
+47,562
New +$2.08M 1.36% 23

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

King Wealth Management Group's ABBV Position: Q1 2026 in Review

King Wealth Management Group increased its AbbVie (ABBV) stake by 0.86% in Q1 2026, buying an estimated $5.1K and bringing the position to 2,692 shares worth $585K. The position accounts for 0.07% of the portfolio, ranked #93.

King Wealth Management Group first reported a position in ABBV in Q2 2013 and has held it in 45 quarters since. The position peaked at $4.81M in Q4 2014. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • King Wealth Management Group held 2,692 shares of AbbVie worth $585K as of Q1 2026.
  • King Wealth Management Group bought 23 AbbVie shares in Q1 2026, an estimated $5.1K.
  • AbbVie made up 0.07% of King Wealth Management Group's portfolio in Q1 2026, its #93 holding.
  • King Wealth Management Group first reported a position in AbbVie in Q2 2013 and has held it in 45 quarters since.
  • King Wealth Management Group's AbbVie position peaked at $4.81M in Q4 2014.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on King Wealth Management Group's 13F filing for Q1 2026, filed 4 May 2026.